Equity Research on Hospira Inc. and Valeant Pharmaceuticals International Inc. -- Drug Delivery Companies Growing in Leaps and Bounds
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 09/20/12 -- has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Drug Delivery industry and are offering free analytical research on (NYSE: HSP) and (NYSE: VRX). Register with us now to have free access to these research reports. Simply click on the link below.
Companies in the drug delivery industry, which includes players such as Hospira Inc. and Valeant Pharmaceuticals International Inc., have been performing well as of late, and many have been taking steps to grow their operations. With a number of factors boosting the outlook for the industry, including an aging population in the U.S. and the upholding of the Affordable Care Act, those that can expand their businesses could be best positioned moving forward. Get your free reports on and at . There is no commitment to join.
ShinesRooms.com is the Ultimate Trading Environment for investors. If you are considering owning Hospira Inc. and Valeant Pharmaceuticals International Inc. then you should sign up for a free membership and our complimentary reports today. Over the last 5 years our returns outpaced any of the major indexes. Sign up today by clicking on the link below to find out what you are missing.
Both of the aforementioned companies have recently been active in increasing their market share. Valeant has been in the spotlight as of late, as it announced it has entered into a multi-billion dollar agreement to acquire Medicis Pharmaceutical Corporation. The acquisition should, among other things, improve Valeant's position in the field of dermatology. report is accessible for free by registering today at
Hospira has also been busy, recently stating that it has agreed to purchase an active pharmaceutical ingredient manufacturing facility as well as an associated R&D facility from Orchid Chemicals & Pharmaceuticals Ltd. report is accessible for free by registering today at
The two stocks research reports are available for free by signing up now on the link below.
Shine's Rooms is the brainchild of David Shine, a 13-year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting-edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.
To view our visit this link .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.09.2012 - 12:00 Uhr
Sprache: Deutsch
News-ID 185254
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Investment Opinion
Diese Pressemitteilung wurde bisher 172 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Equity Research on Hospira Inc. and Valeant Pharmaceuticals International Inc. -- Drug Delivery Companies Growing in Leaps and Bounds"
steht unter der journalistisch-redaktionellen Verantwortung von
Shinesrooms.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
